Phio Pharmaceuticals Corp Stock Analysis

Phio Stock Analysis Notes

The company has price-to-book ratio of 0.74. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Phio Pharmaceuticals Corp recorded a loss per share of 16.08. The entity last dividend was issued on the 15th of January 2020. The firm had 1:9 split on the 5th of July 2024. Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. Phio Pharmaceuticals Corp. was incorporated in 2011 and is headquartered in Marlborough, Massachusetts. Phio Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 12 people. To find out more about Phio Pharmaceuticals Corp contact the company at (508) 767-3861 or learn more at https://phiopharma.com.

Phio Pharmaceuticals Corp Investment Alerts

Phio Pharmaceuticals Corp Upcoming and Recent Events

Phio Largest EPS Surprises

View All Earnings Estimates

Phio Pharmaceuticals Environmental, Social, and Governance (ESG) Scores

Phio Stock Institutional Investors

Note, although Phio Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Phio Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.8 M.

Phio Profitablity

Management Efficiency

Phio Pharmaceuticals Corp has return on total asset (ROA) of (0.6107) % which means that it has lost $0.6107 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2686) %, meaning that it created substantial loss on money invested by shareholders. Phio Pharmaceuticals' management efficiency ratios could be used to measure how well Phio Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of the 8th of November 2024, Return On Tangible Assets is likely to drop to -1.21. In addition to that, Return On Capital Employed is likely to grow to -1.33. At this time, Phio Pharmaceuticals' Total Assets are very stable compared to the past year. As of the 8th of November 2024, Total Current Assets is likely to grow to about 12.1 M, while Non Current Assets Total are likely to drop about 39.9 K.

Technical Drivers

As of the 8th of November, Phio Pharmaceuticals holds the Semi Deviation of 4.89, risk adjusted performance of 0.0651, and Coefficient Of Variation of 1387.77. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Phio Pharmaceuticals, as well as the relationship between them.

Phio Pharmaceuticals Corp Price Movement Analysis

Phio Pharmaceuticals Corp Insider Trading Activities

Phio Pharmaceuticals Outstanding Bonds

Phio Pharmaceuticals Predictive Daily Indicators

Phio Pharmaceuticals Corporate Filings

Phio Pharmaceuticals Forecast Models

Phio Pharmaceuticals' time-series forecasting models are one of many Phio Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Phio Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Phio Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Phio shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Phio Pharmaceuticals. By using and applying Phio Stock analysis, traders can create a robust methodology for identifying Phio entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Phio analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Phio analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Phio Pharmaceuticals Corp stock analysis indicators help investors evaluate how Phio Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Phio Pharmaceuticals shares will generate the highest return on investment. By understating and applying Phio Pharmaceuticals stock analysis, traders can identify Phio Pharmaceuticals position entry and exit signals to maximize returns.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phio Pharmaceuticals Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phio Pharmaceuticals. If investors know Phio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Phio Pharmaceuticals Corp is measured differently than its book value, which is the value of Phio that is recorded on the company's balance sheet. Investors also form their own opinion of Phio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Phio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Phio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Phio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Phio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.